PROJECT SUMMARY
Prenatal alcohol exposure can disrupt normal development, leading to a host of pathologies that can include
facial dysmorphology, growth deficiencies, and central nervous system dysfunction. Compromised brain
development and reduced cognitive capacity are among some of the most devastating of alcohol's adverse
effects. Although alcohol-related neurodevelopmental disorders are completely preventable, 2-5% of live
births in the U.S. are affected by prenatal alcohol exposure, with even higher rates among some populations.
Thus, it is critical that we identify effective treatments and interventions for reducing the adverse
consequences of prenatal alcohol exposure, including compromised neuronal plasticity in the offspring. Using
a rat model, we have found that supplementation with the nutrient choline can reduce the severity of
cognitive deficits associated with developmental alcohol exposure. These benefits are observed even when
choline is administered postnatally and after alcohol exposure has ceased. Specifically, we have found that
choline supplementation up to postnatal day (PD) 30 reduces the severity of alcohol-induced behavioral
deficits on tasks that depend on the functional integrity of the hippocampus. This proposal will examine
whether postnatal choline supplementation mitigates alcohol's effects on hippocampal structural and
functional plasticity, including adult neurogenesis and long-term potentiation, and if choline enhances other
experience-dependent plasticity. We will further investigate whether changes in functional plasticity are
related to choline-induced changes in long-lasting cholinergic functioning. In addition, recent data indicate
that toddlers and children with fetal alcohol spectrum disorders (FASD) are not consuming adequate
amounts of choline and that dietary choline intake correlates with some behavioral outcomes. Thus, we will
also determine the effects of postnatal choline deficiency on behavioral development and hippocampal
plasticity. Elucidation of choline's effects on brain function and plasticity is critical as choline intervention is
already being translated to clinical populations. These studies will not only determine the neural substrates of
choline's actions, but also determine if combination therapies are more effective in improving behavioral
outcome. Moreover, these studies will help determine if dietary intake among children with FASD influences
cognitive functioning. Thus, these studies have important implications for the treatment of FASD.
Public Health Relevance Statement
PROJECT NARRATIVE
Prenatal alcohol exposure disrupts physical, brain and behavioral development, leading to a range of fetal
alcohol spectrum disorders (FASD), a serious, global, and costly public health concern. It is critical that we
identify effective treatments for reducing FASD, particularly the cognitive deficits. This proposal will examine
how nutritional and behavioral factors modify the severity of FASD, which has important implications for
treatment of FASD, and improving the quality of life of affected individuals.
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
073371346
UEI
H59JKGFZKHL7
Project Start Date
01-June-2001
Project End Date
31-March-2028
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$356,198
Direct Costs
$235,882
Indirect Costs
$120,316
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$356,198
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R37AA012446-20
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R37AA012446-20
Patents
No Patents information available for 5R37AA012446-20
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R37AA012446-20
Clinical Studies
No Clinical Studies information available for 5R37AA012446-20
News and More
Related News Releases
No news release information available for 5R37AA012446-20
History
No Historical information available for 5R37AA012446-20
Similar Projects
No Similar Projects information available for 5R37AA012446-20